| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 670.13B | 619.51B | 578.91B | 559.24B | 510.44B |
| Gross Profit | 194.42B | 187.97B | 168.52B | 165.82B | 174.98B |
| EBITDA | 94.26B | 137.31B | 122.42B | 119.75B | 132.80B |
| Net Income | 59.94B | 54.93B | 40.56B | 55.05B | 70.85B |
Balance Sheet | |||||
| Total Assets | 1.24T | 1.14T | 1.13T | 1.03T | 982.83B |
| Cash, Cash Equivalents and Short-Term Investments | 322.92B | 263.87B | 242.67B | 214.71B | 185.64B |
| Total Debt | 244.63B | 252.24B | 259.32B | 253.36B | 252.35B |
| Total Liabilities | 425.98B | 415.48B | 424.35B | 386.72B | 393.24B |
| Stockholders Equity | 809.24B | 720.58B | 696.28B | 636.33B | 584.09B |
Cash Flow | |||||
| Free Cash Flow | 84.80B | 54.86B | 56.35B | 57.69B | 59.60B |
| Operating Cash Flow | 137.99B | 96.66B | 99.16B | 97.95B | 94.83B |
| Investing Cash Flow | -77.12B | -55.08B | -68.59B | -52.01B | -46.29B |
| Financing Cash Flow | -48.28B | -34.22B | -36.12B | -34.57B | -45.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥193.22B | 16.40 | ― | 3.39% | 9.87% | 11.30% | |
76 Outperform | ¥1.50T | 15.26 | 7.13% | 2.01% | 8.17% | 10.92% | |
73 Outperform | ¥9.95B | 6.48 | ― | 3.51% | 20.57% | 61.52% | |
71 Outperform | ¥1.32T | 20.83 | 12.13% | 1.21% | 7.54% | 13.65% | |
71 Outperform | ¥424.20B | 8.30 | 14.28% | 2.40% | 6.38% | 43.23% | |
69 Neutral | ¥270.78B | 13.46 | 2.20% | 2.81% | 0.83% | -21.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |